14-ICML - LUGANO 2017
Malignant lymphomas: focus on new treatments based on immunotherapy
14-ICML - LUGANO 2017
Malignant lymphomas: focus on new treatments based on immunotherapy
Since 2011, the ICML conference has taken place in Lugano every two years with the increasing participation of specialists in lymphomas and related areas. The dominant theme of this edition was immunotherapy, thanks to the presentation of a great amount of clinical data, in particular on new treatments based on CAR-T Cells.
Since 2011, the ICML conference has taken place in Lugano every two years with the increasing participation of specialists in lymphomas and related areas. The dominant theme of this edition was immunotherapy, thanks to the presentation of a great amount of clinical data, in particular on new treatments based on CAR-T Cells.
interviews
Innovative therapies against lymphoma at the 14-ICML conference
en
Prof. Franco Cavalli
The interaction between basic biology and clinical treatment
en
Prof. Jonathan Friedberg
Relapsed/refractory B-cell malignancies: cerdulatinib ph. 2 study
en
Dr. Paul A. Hamlin
Immunotherapy: useful information from lung cancer treatment
en
Prof. Rolf Stahel
Chronic lymphocytic leukemia: a new class of agents and a chemo-free approach
en
Prof. Davide Rossi
Leucemia Linfatica Cronica: agenti mirati, promettenti per future terapie
it
Prof. Davide Rossi
Cooperating to improve the survivorship and patient quality of life
en
Dr. Margaret Foti
Linfoma primario del mediastino: stadiazione migliore con 18-FDG PET-CT
it
Dott. Luca Ceriani